Behcet’s disease and pregnancy: what to expect?

References

• Adolfsson A. 2006. Miscarriage: women’s experience and its cumulative incidence. [Ph.D. Thesis]. Linköping: Linköping University.
   Google Scholar
• Alibaz-Oner F, Karadeniz A, Ylmaz S, Balkarl A, Kimyong G, Yazc A, et al. 2015. Behcet disease with vascular involvement: effects of different therapeutic regimens on the incidence of new relapses. Medicine (Baltimore) 94:e494.
   PubMed Web of Science ®Google Scholar
• Altinbas A, Aytemur K, Tokgozoglu L, Ozturk M, Kosar A, Haznedarodglu IC, et al. 2000. Hyperhomocysteinaemia and activated protein C resistance in Behcet’s disease. Journal of Internal Medicine 248:267–268.
   PubMed Web of Science ®Google Scholar
• Amoura Z, Schermann JM, Wechsler B, Zerah X, Goodeau P. 1994. Transplacental passage of colchicine in familial Mediterranean fever. Journal of Rheumatology 21:383.
   PubMed Web of Science ®Google Scholar
• Bang D, Chun YS, Haam IB, Lee ES, Lee S. 1997. The influence of pregnancy on Behçet’s disease. Yonsei Medical Journal 38:437–443.
   PubMedGoogle Scholar
• Berkenstadt M, Weisz B, Cuckle H, Di-Castro M, Guetta E, Barkai G. 2005. Chromosomal abnormalities and birth defects among couples with colchicine treated familial Mediterranean fever. American Journal of Obstetrics & Gynecology 193:1513–1516.
   PubMed Web of Science ®Google Scholar
• Butta NV, Fernandez-Bello I, Lopez-Longo FJ, Jiminez-Yuste V. 2015. Endothelial dysfunction and altered coagulation as mediators of thromboembolism in Behcet disease. Seminars in Thrombosis and Hemostasis 41:621–628.
   PubMed Web of Science ®Google Scholar
• Chafa O, Fischer AM, Meriane F, Chellali T, Sternberg C, Otmani F, et al. 1992. Behçet syndrome associated with protein S deficiency. Thrombosis and Haemostasis 67:1–3.
   PubMed Web of Science ®Google Scholar
• Djokanovic N, Klieger-Grossmann C, Pupco A, Koren G. 2011. Safety of infliximab use during pregnancy. Reproductive Toxicology 32:93–97.
   PubMed Web of Science ®Google Scholar
• Gatto M, Iaccarino L, Canova M, Zen M, Nalotto L, Ramonda R, et al. 2012. Pregnancy and vasculitis: a systematic review of the literature. Autoimmunity Reviews 11:A447–A459.
   PubMed Web of Science ®Google Scholar
• Gul U. 2000. Pregnancy and Behcet disease. Archives of Dermatology 136:1063–1064.
   PubMedGoogle Scholar
• Gungor AN, Kalkan G, Oguz S, Sen B, Ozoguz P, Takci Z, et al. 2014. Behcet disease and pregnancy. Clinical and Experimental Obstetrics & Gynecology 41:617–619.
   PubMed Web of Science ®Google Scholar
• Hamza M, Elleuch M, Zribi A. 1988. Behçet’s disease and pregnancy. Annals of the Rheumatic Diseases 47:350.
   PubMed Web of Science ®Google Scholar
• Hwang I, Lee CK, Yoo B, Lee I. 2009. Necrotizing villitis and decidual vasculitis in the placentas of mothers with Behcet disease. Human Pathology 40:135–138.
   PubMed Web of Science ®Google Scholar
• Ibrahim SS, Osman R, Awad GA, Mortada ND, Geneidy A. 2016. Low molecular weight heparins for current and future uses: approaches for micro- and nano-particulate delivery. Drug Delivery 23:2661–2667.
   PubMed Web of Science ®Google Scholar
• International Study Group for Behcet’s Disease. 1990. Criteria for diagnosis of Behcet’s disease. Lancet 335:1078–1080.
   PubMed Web of Science ®Google Scholar
• Iskender C, Yasar O, Kaymak O, Yaman ST, Uygur D, Danisman N. 2014. Behçet’s disease and pregnancy: a retrospective analysis of course of disease and pregnancy outcome. The Journal of Obstetrics and Gynaecology Research 40:1598–1602.
   PubMed Web of Science ®Google Scholar
• Jadaon J, Shushan A, Ezra Y, Sela HY, Ozcan C, Rojansky N. 2005. Behçet’s disease and pregnancy. Acta Obstetricia Et Gynecologica Scandinavica 84:939–944.
   PubMed Web of Science ®Google Scholar
• Kanda N, Watanabe S. 2005. Regulatory roles of sex hormones in cutaneous biology and immunology. Journal of Dermatological Science 38:1–7.
   PubMed Web of Science ®Google Scholar
• Krause I, Weinberger A. 2002. Vasculo-Behçet’s disease. The Israel Medical Association Journal: IMAJ 4:636–637.
   PubMed Web of Science ®Google Scholar
• Levi M, Keller TT, Van Gorp E, Ten Cate H. 2003. Infection and inflammation and the coagulation system. Cardiovascular Research 60:26–39.
   PubMed Web of Science ®Google Scholar
• Luan Z-G, Naranpurev M, Ma X-C. 2014. Treatment of low molecular weight heparin inhibits systemic inflammation and prevents endotoxin-induced acute lung injury in rats. Inflammation 37:924–932.
   PubMed Web of Science ®Google Scholar
• Mader R, Ziv M, Adawi M, Mader R, Lavi I. 1999. Thrombophilic factors and their relation to thromboembolic and other clinical manifestations in Behcet’s disease. Journal of Rheumatology 26:2404–2408.
   PubMed Web of Science ®Google Scholar
• Madkour M, Kudwah A. 1978. Behçet’s disease. British Medical Journal 2:1786.
   PubMed Web of Science ®Google Scholar
• Marsal S, Falga C, Simeon CP, Vilardelli M, Bosch JA. 1997. Behcet’s disease and pregnancy relationship study. British Journal of Rheumatology 36:234–238.
   PubMedGoogle Scholar
• Martin JA, Hamilton BE, Osterman MJ, Curtin SC, Matthews T. 2015. Births: final data for 2013. National vital statistics reports: from the Centers for Disease Control and Prevention, National Center for Health Statistics, National Vital Statistics System, vol. 64. p. 1–65.
   Google Scholar
• McKay LI, Cidlowski JA. 1999. Molecular control of immune/inflammatory responses: interactions between nuclear factor-kappa B and steroid receptor-signaling pathways. Endocrine Reviews 20:435–459.
   PubMed Web of Science ®Google Scholar
• Miyaura H, Iwata M. 2002. Direct and indirect inhibition of Th1 development by progesterone and glucocorticoids. Journal of Immunology (Baltimore, MD: 1950) 168:1087–1094.
   PubMed Web of Science ®Google Scholar
• Nalcaci M, Pekcelen Y. 1998. Antithrombin III, protein C and protein S plasma levels in patients with Behcet’s disease. Journal of International Medical Research 26:206–208.
   PubMed Web of Science ®Google Scholar
• Noel N, Weschler B, Nizard J, Costedoat-Chalumeau N, Boutin Du LT, Dommergues M, et al. 2013. Behçet’s disease and pregnancy. Arthritis and Rheumatism 65:2450–2456.
   PubMed Web of Science ®Google Scholar
• Oh SH, Kwon JY, Lee JH, Han EC, Bang D. 2009. Behcet’s disease: remission of patient symptoms after oral contraceptive therapy. Clinical and Experimental Dermatology 34:e88–e90.
   PubMed Web of Science ®Google Scholar
• Ozoran K, Dugun N, Gurler A, Tutkak H, Tokgoz G. 1995. Plasma von Willebrand factor, tissue plasminogen activator, plasminogen activator inhibitor, and antithrombin III levels in Behcet’s disease. Scandinavian Journal of Rheumatology 24:376–382.
   PubMed Web of Science ®Google Scholar
• Regan L, Rai R. 2000. Epidemiology and the medical causes of miscarriage. Best Practice & Research Clinical Obstetrics & Gynaecology 14:839–854.
   PubMed Web of Science ®Google Scholar
• Saadoun D, Wechsler B, Desseaux K, Huong DLT, Amoura Z, Resche-Rigon M, et al. 2010. Mortality in Behcet’s disease. Arthritis and Rheumatism 62:2806–2812.
   PubMed Web of Science ®Google Scholar
• Sakane T, Takeno M, Suzuzki N, Inaba G. 1999. Behçet’s disease. The New England Journal of Medicine 341:1284–1291.
   PubMed Web of Science ®Google Scholar
• Shehto NM, Ghosh K, Abdul Kader B, Ad Assad HS. 1992. Extensive venous thrombosis in a case of Behcet’s disease associated with heterozygous protein C deficiency. Thrombosis and Haemostasis 67:283.
   PubMed Web of Science ®Google Scholar
• Toydemir PB, Elhan AH, Tukun A, Toydemir R, Gurler A, Tuzuner A, et al. 2000. Effects of factor V gene G1691A, methylenetetrahydrofolate reductase gene C677T, and prothrombin gene G20210A mutations on deep venous thrombogenesis in Behcet’s disease. Journal of Rheumatology 27:2849–2854.
   PubMed Web of Science ®Google Scholar
• Uzun S, Alpsoy E, Durdu M, Akman A. 2003. The clinical course of Behçet’s disease in pregnancy: a retrospective analysis and review of the literature. The Journal of Dermatology 30:499–502.
   PubMed Web of Science ®Google Scholar
• Wang H, Bhutta ZA, Coates MM, Coggeshall M, Dandona L, Diallo K, et al. 2016. Global, regional, national, and selected subnational levels of stillbirths, neonatal, infant, and under-5 mortality, 1980–2015: a systematic analysis for the Global Burden of Disease Study 2015. The Lancet 388:1725–1774.
   PubMed Web of Science ®Google Scholar
• Wilcox AJ, Weinberg CR, O’Connnor JF, Baird DD, Schlatterer JP, Canfield RE, et al. 1988. Incidence of early loss of pregnancy. The New England Journal of Medicine 319:189–194.
   PubMed Web of Science ®Google Scholar